Drug Alternatives News 2007-03-02
-
Callisto Pharmaceuticals Opens L-Annamycin Phase I Clinical Trial … – Drug Newswire (press release)
Callisto Pharmaceuticals Opens L-Annamycin Phase I Clinical Trial …
Drug Newswire (press release), CT -9 hours ago
… activity against resistant diseases and significantly reduced cardiotoxicity, or damage to the heart, compared to currently available drug alternatives. … -
SXC Health Solutions receives 2007 Rx Benefit Innovation Award – Drug Newswire (press release)
SXC Health Solutions receives 2007 Rx Benefit Innovation Award
Drug Newswire (press release), CT -Feb 28, 2007
… that nearly 40% of consumers who used the tool to investigate more cost-effective drug alternatives made the decision to use a lower cost product. … -
Pharmacy Benefit Management Institute Recognizes Innovation in … – Business Wire (press release)
Pharmacy Benefit Management Institute Recognizes Innovation in …
Business Wire (press release), CA -Feb 22, 2007
… beneficiaries to run real-time trial adjudications to compare the cost impact of prescription drug alternatives, based on their own benefit design. … -
SXC Health Solutions receives 2007 Rx Benefit Innovation Award – Earthtimes.org
SXC Health Solutions receives 2007 Rx Benefit Innovation Award
Earthtimes.org -Feb 22, 2007
… that nearly 40% of consumers who used the tool to investigate more cost-effective drug alternatives made the decision to use a lower cost product. …
